Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01761422 · ClinicalTrials.gov registry record
Myocardial Inflammation in Systemic Lupus Erythematosus
A clinical trial of SLE, sponsored by Stacy Ardoin MD.
- Active
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT01761422: Active study of SLE, sponsored by Stacy Ardoin MD.
NCT01761422 is a study of SLE that is active but no longer recruiting, run by Stacy Ardoin MD. The registered enrollment target is 40 participants, below the 86-participant average among 9 other SLE trials with a reported enrollment target (53% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01761422, a study of SLE, is active but no longer recruiting, sponsored by Stacy Ardoin MD.
- ACTIVE NOT RECRUITING
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal is to assess for myocardial edema on cardiac MRI during SLE flare to assess for myocardial inflammation.
Primary Outcome
Compare T2 edema at flare and 3 months later
Conditions Studied
Study Locations (1)
Ohio
- Stacy Payne Ardoin - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2012-07-01 |
| Est. Completion | 2026-11-01 |
What the registry record for NCT01761422 still lists
NCT01761422 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 86-participant average among 9 other SLE trials with a reported enrollment target (53% lower).
The record links to 1 condition, with SLE appearing as the primary indexed condition, and to 0 interventions.
NCT01761422 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT01761422 about?
NCT01761422 is a clinical study titled "Myocardial Inflammation in Systemic Lupus Erythematosus". The goal is to assess for myocardial edema on cardiac MRI during SLE flare to assess for myocardial inflammation.
What is the current status of trial NCT01761422?
This trial is currently active not recruiting. The enrollment target is 40 participants. The study started on 2012-07-01. Estimated completion is 2026-11-01.
What conditions does trial NCT01761422 study?
This clinical trial studies the following conditions: SLE.
Who is sponsoring clinical trial NCT01761422?
This trial is sponsored by Stacy Ardoin MD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01761422 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for SLE
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01761422's enrollment target sits among peer trials
40 6th of 9 higher than 4 of 9 other SLE trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other SLE trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus
RECRUITING · Phase 1
-
Safety and Efficacy of ONT01 in Lupus
RECRUITING · Early Phase 1
-
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
RECRUITING · Phase 1
-
UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients
RECRUITING · Phase 1
-
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus
RECRUITING · Phase 2
-
Vaccine Hesitancy in Black/African Americans With Rheumatic Diseases
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI